Behind the markets
Behind the markets

Daily Trades

TRADE ALERT: Sell Viking Therapeutics for a 273% gain

I made a bet to hold shares and see how the market digested the stock.
Learn More

TRADE ALERT: Viking Jumps 121% on Strong Results

That was the first thought I had when I saw that shares of Viking Therapeutics (SYM: VKTX) jumped 121% yesterday after posting great results for its weight-loss drug.
Learn More

TRADE ALERT: Krystal Bio Jumps 40% on Strong Earnings

Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS). 
Learn More

TRADE ALERT: Sell half of Viking for a 63% Gain

I recommend selling half your shares of Viking Therapeutics (SYM: VKTX) here at $30.58, a 63% gain from our average recommended price of $18.71. 
Learn More

October 2023 Issue: Updates

The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
Learn More

SPECIAL REPORT: The King Kong of New Drugs: Companies at the Forefront of the Weight-Loss Revolution

The Wall Street Journal calls this new drug “King Kong”…
Learn More

September 2023 Issue: Recursion Pharmaceuticals (SYM: RXRX)

The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
Learn More

TRADE ALERT: Eli Lilly up $50 on weight-loss drug

Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

SPECIAL REPORT: “The King Kong of New Drugs: Companies at the Forefront of the Weight-Loss Revolution.”

This new drug is predicted to help as many as 132 million Americans live longer, healthier and happier lives.
Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

797 subscribers

Behind the Markets: independent research for independent investors.

Behind the Markets
In this video, we'll explore the recent turbulence affecting small-cap stocks, particularly in the biotech sector. Dylan will share essential strategies to maintain your composure amidst market chaos. Drawing from his early experiences on Wall Street and advice from mentors, Dylan explains why it's crucial not to "pee on the rug at the first sound of thunder." You'll learn about the importance of investing in solid businesses and not panicking at the first sign of trouble. If you're feeling uncertain about your investments, this video provides practical advice and encouragement. Please hit like, subscribe, and share if you find these insights helpful. Remember to stay calm and resilient, because steady wins the race! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkVoQ09KWVBnT3lB

Handling Market Dips: A Little Advice from a Wall Street Insider

In this video, we dive deep into the current geopolitical tensions involving the United States, Israel, and Iran. Our video dissects the possible repercussions of an escalated conflict in the Middle East and why it might be a catastrophic mistake for the U.S. to engage in a war that doesn't align with national security priorities. We explore the historical context of the shadow war between Israel and Iran, and the implications of Israel's recent actions that indirectly involved Iranian territory. This includes the strike on an Iranian consulate, a move that escalated tensions but was met with a measured response from Iran, indicating a possible avoidance of further escalation. Additionally, the video sheds light on the broader implications for U.S. foreign policy, emphasizing the importance of focusing on domestic priorities and strategic international investments, like supporting Ukraine and monitoring developments in Taiwan due to its significance in semiconductor production. Join us as we unravel the complexities of these interactions, the potential mistakes in escalating conflicts, and the strategic choices the U.S. might consider to maintain global stability while securing its interests. Your thoughts and opinions are invaluable—share them in the comments below and let's discuss what the future should hold for U.S. involvement in Middle East affairs. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxROHJOTHBIX2t3

Israel vs. Iran: The Mistake That Could Drag the U.S. into War

In today’s video, we delve deep into the often overlooked geopolitical risks associated with our global dependency on artificial intelligence (AI) technologies. While AI continues to shape the future in extraordinary ways, there's a critical factor that might disrupt this progress: the semiconductor supply chain. Most of the world's advanced semiconductors, crucial for everything from mobile phones to AI systems, are manufactured in Taiwan by Taiwan Semiconductor Manufacturing Company (TSMC). However, with rising tensions in the region and China's increasing assertiveness towards Taiwan, the stability of this supply chain is under significant threat. In the past month alone, major companies like Samsung, TSMC, and Intel have received substantial funding from the U.S. government, aimed at boosting semiconductor production within the United States. This strategic move highlights a growing awareness of the risks posed by potential conflicts in Taiwan—a scenario that could have profound impacts on global technology supply chains. Join us as we analyze these complex dynamics, including the strategic moves by global and national powers to secure semiconductor production, and discuss the potential implications on AI development and broader technological advancements. We'll also offer insights into the actions companies and governments are taking to mitigate these risks. Don't forget to like, subscribe, and click the bell icon to stay updated on our latest content, where we continue to uncover the critical intersections between technology and geopolitics. Share your thoughts in the comments below: How do you think these developments will affect the future of technology and global stability? ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxzZ0ZxaUhtYVpJ

The Looming Threat to Nvidia and AI

Load More... Subscribe

Recent posts

Chart of Day: Johnson & Johnson (JNJ) – 4/25

These Two Oversold Gaming Stocks Are Ready to Bounce – 4/25

Apple Could Soar on These 3 Strong Catalysts

Chart of Day: Marathon Digital (MARA) – 4/24

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

TRADE ALERT: Sell Viking Therapeutics for a 273% gain

I made a bet to hold shares and see how the market digested the stock.
Learn More

TRADE ALERT: Viking Jumps 121% on Strong Results

That was the first thought I had when I saw that shares of Viking Therapeutics (SYM: VKTX) jumped 121% yesterday after posting great results for its weight-loss drug.
Learn More

TRADE ALERT: Krystal Bio Jumps 40% on Strong Earnings

Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS). 
Learn More

TRADE ALERT: Sell half of Viking for a 63% Gain

I recommend selling half your shares of Viking Therapeutics (SYM: VKTX) here at $30.58, a 63% gain from our average recommended price of $18.71. 
Learn More

October 2023 Issue: Updates

The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
Learn More

SPECIAL REPORT: The King Kong of New Drugs: Companies at the Forefront of the Weight-Loss Revolution

The Wall Street Journal calls this new drug “King Kong”…
Learn More

September 2023 Issue: Recursion Pharmaceuticals (SYM: RXRX)

The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
Learn More

TRADE ALERT: Eli Lilly up $50 on weight-loss drug

Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
Learn More

June 2023 Issue: 3 Stocks Riding the Weight Loss Wave – (LLY), (NVO), (VKTX)

Let's start by closing out one of our older positions for a small profit. 
Learn More

SPECIAL REPORT: “The King Kong of New Drugs: Companies at the Forefront of the Weight-Loss Revolution.”

This new drug is predicted to help as many as 132 million Americans live longer, healthier and happier lives.
Learn More

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2024 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.